| 000 | 01656 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516093123.0 | ||
| 264 | 0 | _c20130426 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1439-0795 | ||
| 024 | 7 |
_a10.1055/s-0032-1309004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSeemüller, F | |
| 245 | 0 | 0 |
_aThe relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone. _h[electronic resource] |
| 260 |
_bPharmacopsychiatry _cNov 2012 |
||
| 300 |
_a292-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAkathisia, Drug-Induced _xpsychology |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aAnxiety _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHaloperidol _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPsychiatric Status Rating Scales _xstatistics & numerical data |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aRisperidone _xadverse effects |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 650 | 0 | 4 | _aSuicidal Ideation |
| 700 | 1 | _aLewitzka, U | |
| 700 | 1 | _aBauer, M | |
| 700 | 1 | _aMeyer, S | |
| 700 | 1 | _aMusil, R | |
| 700 | 1 | _aSchennach, R | |
| 700 | 1 | _aRiedel, M | |
| 700 | 1 | _aDoucette, S | |
| 700 | 1 | _aMöller, H-J | |
| 773 | 0 |
_tPharmacopsychiatry _gvol. 45 _gno. 7 _gp. 292-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0032-1309004 _zAvailable from publisher's website |
| 999 |
_c21799348 _d21799348 |
||